致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Rhesus macaque LILRB1/CD85j/ILT2, His-tag
目录号 NBL-240845
别名 LILRB1/CD85j/ILT2; ILT2; ILT-2; ILT2FLJ37515; LILRB1; LIR1; MIR7; CD85J; XXbac-BCX85G21.4
外观 see COA
分子量 Ser17-His456
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 F7H3G7
备注2
目录号 规格 价格 库存状态  
NBL-240845-100ug 100ug Inquire Inquire
NBL-240845-1mg 1mg Inquire Inquire
NBL-240845-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Rhesus macaque LILRB1/CD85j/ILT2, His-tag


Catalog#:

NBL-240845


Description:

NebuSelect™ Recombinant Rhesus macaque LILRB1/CD85j/ILT2, His-tag(Cat#NBL-240845) is expressed in HEK293 with His tag at the C-Terminus.It contains Ser17-His456.


Species:

Rhesusmacaque


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 48.5 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.


Target Name:

LILRB1/CD85j/ILT2; ILT2; ILT-2; ILT2FLJ37515; LILRB1; LIR1; MIR7; CD85J; XXbac-BCX85G21.4


Target Information:

LILRB1, also known as CD85j and ILT2, is a 110 kDa transmembrane glycoprotein in the LILR immunoregulatory protein family. Mature human LILRB1 consists of a 438 amino acid (aa) extracellular domain (ECD) with 4 tandem Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 4 inhibitory ITIM motifs.LILRB1 is a receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. Receptor for H301/UL18, a human cytomegalovirus class I MHC homolog. Ligand binding results in inhibitory signals and down-regulation of the immune response.


Amino Acid Sequence: 

Ser17-His456


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品